Detail of the clinical trial
| Title of the trial | A Randomized, Double-Blind Study Evaluating the Efficacy, Safety and Immunogenicity of ABP 798 Compared with Rituximab in Subjects with CD20 Positive B-Cell Non-Hodgkin Lymphoma (NHL) |
|---|---|
| EudraCT number | 2013-005542-11 |
| Protocol number | 20130109 |
| Sponsor | Amgen Inc.,One Amgen Center Drive,Thousand Oaks,CA 91320 |
| Indications | Hemato-oncology |
| Diagnosis | Non-Hodgkin lymphoma |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2014 |
| Date of approval by Institute (SÚKL) | 30.7.2014 |
| Date of approval by EC | 22.5.2014 |
| Date of initiation CT in ČR | 13.5.2016 |
| Date of ending CT in ČR | 28.6.2019 (10.7.2019 |
| Notice | |
| Sites |
Oblastní nemocnice Mladá Boleslav, a.s.,Hematologicko-transfuzní oddělení,V. Klementa 147 ,Mladá Boleslav,293 50 Fakultní nemocnice Královské Vinohrady,Interní hematologická klinika,Šrobárova 1150/50 ,Praha 10,100 34 Fakultní nemocnice v Motole,Onkologická klinika ,V Úvalu 84,Praha 5,150 06 Fakultní nemocnice Ostrava,Klinika hematoonkologie ,17. listopadu 1790,Ostrava,708 52 |
cz